huperzine a has been researched along with lactoferrin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hua, H; Jiang, Y; Meng, Q; Mu, H; Sun, K; Wang, A; Wang, Y; Wu, Z | 1 |
| Ding, Z; Han, T; Jiang, Y; Liu, C; Zhai, W; Zhuang, N | 1 |
2 other study(ies) available for huperzine a and lactoferrin
| Article | Year |
|---|---|
Intranasal delivery of Huperzine A to the brain using lactoferrin-conjugated N-trimethylated chitosan surface-modified PLGA nanoparticles for treatment of Alzheimer's disease.
Topics: Administration, Intranasal; Alkaloids; Alzheimer Disease; Animals; Brain; Chitosan; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Lactoferrin; Mice; Nanoparticles; Neuroprotective Agents; Particle Size; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Sesquiterpenes; Tissue Distribution | 2018 |
The Optimization Design Of Lactoferrin Loaded HupA Nanoemulsion For Targeted Drug Transport Via Intranasal Route.
Topics: Administration, Intranasal; Alkaloids; Alzheimer Disease; Animals; Biological Transport; Blood-Brain Barrier; Brain; Cell Line; Drug Liberation; Emulsions; Humans; Lactoferrin; Male; Nanoparticles; Nasal Mucosa; Particle Size; Phase Transition; Rats, Wistar; Sesquiterpenes; Solubility; Static Electricity; Tissue Distribution | 2019 |